Tonix Pharmaceuticals Holding Corp. (TNXP)
5.28
-0.09
(-1.68%)
USD |
NASDAQ |
Oct 29, 16:00
5.28
0.00 (0.00%)
Pre-Market: 20:00
Tonix Pharmaceuticals Market Cap : 88.66M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 88.66M |
| October 28, 2026 | 90.17M |
| October 27, 2026 | 90.51M |
| October 26, 2026 | 89.00M |
| October 23, 2026 | 86.82M |
| October 22, 2026 | 86.14M |
| October 21, 2026 | 91.18M |
| October 20, 2026 | 97.06M |
| October 19, 2026 | 96.22M |
| October 16, 2026 | 101.43M |
| October 15, 2026 | 107.81M |
| October 14, 2026 | 107.47M |
| October 13, 2026 | 102.94M |
| October 12, 2026 | 111.50M |
| October 09, 2026 | 122.58M |
| October 08, 2026 | 122.25M |
| October 07, 2026 | 126.78M |
| October 06, 2026 | 129.22M |
| October 05, 2026 | 135.51M |
| October 02, 2026 | 149.62M |
| October 01, 2026 | 154.99M |
| September 30, 2026 | 163.56M |
| September 29, 2026 | 162.05M |
| September 28, 2026 | 166.24M |
| September 25, 2026 | 165.57M |
| Date | Value |
|---|---|
| September 24, 2026 | 162.89M |
| September 23, 2026 | 171.95M |
| September 22, 2026 | 177.83M |
| September 21, 2026 | 180.01M |
| September 18, 2026 | 182.53M |
| September 17, 2026 | 191.77M |
| September 16, 2026 | 197.48M |
| September 15, 2026 | 195.13M |
| September 14, 2026 | 196.97M |
| September 11, 2026 | 199.32M |
| September 10, 2026 | 206.21M |
| September 09, 2026 | 215.45M |
| September 08, 2026 | 220.99M |
| September 04, 2026 | 220.65M |
| September 03, 2026 | 224.51M |
| September 02, 2026 | 224.68M |
| September 01, 2026 | 234.76M |
| August 31, 2026 | 236.77M |
| August 28, 2026 | 228.21M |
| August 27, 2026 | 227.70M |
| August 26, 2026 | 229.05M |
| August 25, 2026 | 229.38M |
| August 24, 2026 | 209.06M |
| August 21, 2026 | 210.74M |
| August 20, 2026 | 208.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 63.55M |
| Nektar Therapeutics | 1.337B |
| Heron Therapeutics, Inc. | 55.78M |
| ACADIA Pharmaceuticals, Inc. | 3.573B |
| Alnylam Pharmaceuticals, Inc. | 23.27B |
Market Cap Related Metrics
| PS Ratio | 2.316 |
| Price to Book Value | 0.3989 |
| Price | 5.28 |
| Earnings Yield | -244.9% |